Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This Phase I/II study is designed to assess the safety and therapeutic effect of INCB007839
in combination with trastuzumab and vinorelbine in patients with metastatic HER2+ breast
cancer.